Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | GRM1 | Q13255 | 10/20 | 0.39 |
| ▸ | GRM5 | P41594 | 9/20 | 0.39 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31208023 | 1.00 | CYP11B2 (0.40) | CYP11B2GRM1GRM5PDK4NAMPT | |
| SCHEMBL26026978 | 0.86 | GRM1 (0.38) | CYP11B2GRM1GRM5PDK4NAMPT | |
| SCHEMBL25431228 | 0.80 | PDK4 (0.37) | GRM1GRM5PDK4NAMPTJAK1 | |
| SCHEMBL25362816 | 0.76 | GRM1 (0.41) | GRM1GRM5PDK4NAMPTNR1H2 | |
| SCHEMBL30496081 | 0.76 | GRM1 (0.41) | GRM1GRM5PDK4NAMPTNR1H2 | |
| SCHEMBL25431963 | 0.76 | GRM1 (0.43) | GRM1GRM5PDK4JAK1 | |
| SCHEMBL31208020 | 0.76 | GRM1 (0.43) | GRM1GRM5PDK4JAK1 | |
| SCHEMBL31208014 | 0.75 | PDE4B (0.46) | EHMT2 | |
| SCHEMBL25432160 | 0.75 | PDE4B (0.46) | EHMT2 | |
| SCHEMBL31208006 | 0.74 | GRM1 (0.38) | GRM1GRM5PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674841-A2 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2026-01-07 | — | — | EP | disclosed |
| EP-4444305-A2 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023156386-A2 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2023-08-24 | — | — | WO | disclosed |